Castle Biosciences, Inc. Stock 12‑Month Price Target Raised to $43.56, Implies 63% Upside

• According to estimates from 9 analysts, Castle Biosciences, Inc. stock's average price target has risen from $42.78 to $43.56, with forecasts ranging from $35 to $57 per share
• Based on the Jul. 30 closing price, the updated target implies approximately 63% potential upside
• Consensus rating remains at “Buy” across 9 covering analysts, with 9 Buys, 0 Holds and 0 Sells

Explore more price target data and ratings for Castle Biosciences, Inc. on the , and track all previous and future analyst recommendations for Castle Biosciences, Inc. in the dedicated .

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.